Skip to search.
 TSX Down 1.14% TSX Ventures Down 1.33%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.14 Up 0.00(2.37%) 4:02PM EDT
Prev Close:0.14
Open:0.14
Bid:0.10 x 10000
Ask:0.15 x 2300
1y Target Est:0.96
Beta:-1.04864
Earnings Date:May 11 - May 16 (Est.)
Day's Range:0.13 - 0.14
52wk Range:0.06 - 0.29
Volume:1,033,093
Avg Vol (3m):757,313
Market Cap:34.29M
P/E (ttm):N/A
EPS (ttm):-0.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBUp 2.37%34.29M
GILDDown 2.06%118.08B
MRKDown 0.40%152.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):229.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback